Named as a key player in 132 of our reports, across 33 regions and countries.
Our reports that name Boehringer Ingelheim International GmbH as a key player, by category and place.
Markets where they are a key player. Each opens the market's statistics for every place we cover.
None of their markets match.
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Named as key players in the same markets as Boehringer Ingelheim International GmbH (number of shared markets).
Bayer AG3 shared markets
GSK PLC3 shared markets
Merck & Co., Inc.3 shared markets
Novartis AG3 shared markets
Johnson & Johnson2 shared markets
Reckitt Benckiser Group PLC2 shared markets
Sanofi2 shared markets
Sun Pharmaceutical Industries Ltd.2 shared markets
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
The topics of the markets Boehringer Ingelheim International GmbH is in.
Stories on the topics Boehringer Ingelheim International GmbH works in.
170 of 194 WHO member states report use of traditional medicine. Herbal products are popular, but quality and…
Read
About 3 in 10 US adults sleep less than 7 hours. Melatonin helps with jet lag and shift work, but its effect…
Read
More than 90% of US women and 97% of men do not eat enough fibre. Prebiotics are the fibres that feed helpful…
ReadSearch all reports for Boehringer Ingelheim International GmbH All companies